Тревожно-депрессивные расстройства в кардиологической практике: возможности применения D,L-Гопантеновой кислоты

2. Федотова А.В. Тревожно-депрессивные расстройства в общеклинической практике. Рациональная фармакотерапия в кардиологии. 2008; 3: 83–8. / Fedotova A.V. Trevozhno-depressivnye rasstroistva v obshcheklinicheskoi praktike. Ratsional'naia farmakoterapiia v kardiologii. 2008; 3: 83–8. [in Russian]
3. Suls J, Bunde J. Anger, Anxiety, and Depression as Risk Factors for Cardiovascular Disease: The Problems and Implications of Overlapping Affective Dispositions. Psychological Bulletin 2005; 131 (2): 260–300. DOI: 10.1037/0033-2909.131.2.260
4. Краснов В.Н. Образовательная программа по депрессивным расстройствам. В 3 т. Т. 2. М.: Московский НИИ психиатрии, 2010. / Krasnov V.N. Obrazovatel'naia programma po depressivnym rasstroistvam. V 3 t. T. 2. M.: Moskovskii NII psikhiatrii, 2010. [in Russian]
5. Оганов Р.Г. Материалы симпозиума: «Депрессия в кардиологии: больше, чем фактор риска». Российский национальный конгресс кардиологов. М., 2003; с. 1–4. / Oganov R.G. Materialy simpoziuma: "Depressiia v kardiologii: bol'she, chem faktor riska". Rossiiskii natsional'nyi kongress kardiologov. M., 2003; s. 1–4. [in Russian]
6. Чазов Е.И. Депрессия как фактор развития и прогрессирования сердечно-сосудистых заболеваний. Сердечная недостаточность. 2003; 1: 6–8. / Chazov E.I. Depressiia kak faktor razvitiia i progressirovaniia serdechno-sosudistykh zabolevanii. Serdechnaia nedostatochnost'. 2003; 1: 6–8. [in Russian]
7. Carney RM, Freeland KE, Sheline YI et al. Depression and coronary heart disease: a review for cardiologists. Clin Cardiol 1997; 20: 196–200.
8. Januzzi JL Jr, Stern TA, Pasternak RC et al. The influence of anxiety and depression on outcomes of patients with coronary artery disease. Arch Intern Med 2000; 160: 1913–21.
9. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease. Arch Gen Psychiatry 1998; 55: 580–92.
10. Freedland K, Rich M, Skala J et al. Prevalence of depression in hospitalized patients with congestive heart failure. Psychosom Med 2003; 65: 119–28.
11. Easton K, Coventry P, Lovell K et al. Prevalence and Measurement of Anxiety in Samples of Patients With Heart Failure. J Cardiovascular Nursing 2016; 31 (4): 367–79. DOI: 10.1097/jcn.0000000000000265
12. Чазов Е.И., Оганов Р.Г., Погосова Г.В. и др. Клинико-эпидемиологическая программа изучения депрессий в кардиологической практике: у больных артериальной гипертонией и ишемической болезнью сердца (КООРДИНАТА): результаты многоцентрового исследования. Кардиология. 2007; 47 (3): 28–37. / Chazov E.I., Oganov R.G., Pogosova G.V. i dr. Kliniko-epidemiologicheskaia programma izucheniia depressii v kardiologicheskoi praktike: u bol'nykh arterial'noi gipertoniei i ishemicheskoi bolezn'iu serdtsa (KOORDINATA): rezul'taty mnogotsentrovogo issledovaniia. Kardiologiia. 2007; 47 (3): 28–37. [in Russian]
13. Погосова Г.В., Ромасенко Л.В. Клинико-эпидемиологические характеристики пациентов пожилого возраста, страдающих сердечно-сосудистыми заболеваниями, коморбидными с депрессивными расстройствами (по результатам многоцентрового проспективного исследования КООРДИНАТА). Терапевтический архив. 2007; 10: 79–82. / Pogosova G.V., Romasenko L.V. Kliniko-epidemiologicheskie kharakteristiki patsientov pozhilogo vozrasta, stradaiushchikh serdechno-sosudistymi zabolevaniiami, komorbidnymi s depressivnymi rasstroistvami (po rezul'tatam mnogotsentrovogo prospektivnogo issledovaniia KOORDINATA). Therapeutic Archive. 2007; 10: 79–82. [in Russian]
14. Davidson KW. Depression and Coronary Heart Disease. ISRN Cardiology 2012; 1–18. DOI: 10.5402/2012/743813
15. Wulsin LR. Is Depression a Major Risk Factor for Coronary Disease? A Systematic Review of the Epidemiologic Evidence. Harvard Rev Psychiatry 2004; 12 (2): 79–93. DOI: 10.1080/10673220490447191
16. Black D, Zimmerman M, Coryell W. Cigarette smoking and psychiatric disorder in a community sample. Ann Clin Psychiatry 1999; 11: 129–36.
17. Kritz-Silverstein D, Barrett-Connor E, Corbeau C. Crosssectional and prospective study of exercise and depressed mood in the elderly: The Rancho Benardo study. Am J Epidemiol 2000; 153: 596–603.
18. Weidner G, Sexton G, McLellarn R et al. The role of Type A behavior and hostility in an elevation of plasma lipids in adult women and men. Psychosomatic Med 1987; 51: 112–22.
19. Anderson RJ, Freedland K, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: A metaanalysis. Diabetes Care 2001; 24: 1069–78.
20. Lauzon C, Beck CA, Huynh T et al. Depression and prognosis following hospitaladmission because of acute myocardial infarction. Can Med Assoc J 2003; 168: 547–52.
21. Van Melle J P, de Jonge P, Spijkerman TA et al. Prognostic Association of Depression Following Myocardial Infarction With Mortality and Cardiovascular Events: A Meta-analysis. Psychosomatic Med 2004; 66 (6): 814–22. DOI: 10.1097/01.psy.0000146294.82810.9
22. Barth J, Schumacher M, Herrmann‐Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: A meta‐ analysis. Psychosom Med 2004; 66: 802–13.
23. Ladwig KH, Roll G, Breithardt G et al. Post‐infarction depression and incomplete recovery 6 months after acute myocardial infarction. Lancet 1994; 343: 20–3.
24. Soderman E, Lisspers J, Sundin O. Depression as a predictor of return to work in patients with coronary artery disease. Soc Sci Med 2003; 56: 193–202.
25. DiMatteo M, Lepper H, Croghan T. Depression is a risk factor for noncompliance with medical treatment. Arch Intern Med 2000; 160: 2101–7.
26. Lane D, Carroll D, Ring C et al. Predictors of attendance at cardiac rehabilitation after myocardial infarction. J Psychosom Res 2001; 51: 497–501.
27. Rutledge Т, Vaccarino V, Johnson BD et al. Depression and cardiovascular health care costs among women with suspected myocardial ischemia. Prospective results from the WISE (Women’s Ischemia Syndrome Evaluation) Study, 13. J Am College Cardiol 2009; 53 (2): 176–83.
28. Frasure-Smith N, Lesperance F, Gravel G et al. Depression and health-care costs daring the first year following myocardial infarction. J Psychosomatic Res 2000; 48 (4–5): 471–8.
29. Lange HW, Herrmann-Lingen C. Depressive symptoms predict recurrence of atrial fibrillation after cardioversion. J Psychosom Res 2007; 63: 509–13.
30. Frasure-Smith N, Lespérance F, Habra M et al. Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure. Circulation 2009; 120 (2): 134–40. DOI: 10.1161/CIRCULATIONAHA.109.851675
31. Von Eisenhart Rothe AF, Goette A, Kirchhof P et al. Depression in paroxysmal and persistent atrial fibrillation patients: a cross-sectional comparison of patients enroled in two large clinical trials. Europace 2014; 16: 812–9.
32. Дума С.Н. Оценка клинической эффективности нейпротекторов, влияющих на систему гамма-аминомасляной кислоты, при лечении когнитивных расстройств у пациентов с дисциркуляторной энцефалопатией I–II стадий. Фарматека. 2010; 15: 96–100. / Duma S.N. Otsenka klinicheskoi effektivnosti neiprotektorov, vliiaiushchikh na sistemu gamma-aminomaslianoi kisloty, pri lechenii kognitivnykh rasstroistv u patsientov s distsirkuliatornoi entsefalopatiei I–II stadii. Farmateka. 2010; 15: 96–100. [in Russian]
33. Skoog I, Gustafson D. Clinical trials for primary prevention in dementia. In: Dementia therapeutic research. Rockwood K, Gauthier S, editors. London and New York: Taylor a Francis 2006; p. 189–212.
34. Obisesan TO, Obisesan OA, Martins S et al. High blood pressure, hypertension, and high pulse pressure are associated with poorer cognitive function in persons aged 60 and older: the Third National Health and Nutrition Examination Survey. J Am Geriatr Soc 2008; 56: 501–9. DOI: 10.1111/j.1532-5415.2007.01592.x
35. Парфенов В.А., Старчина Ю.А. Когнитивные нарушения у пациентов с артериальной гипертензией и их лечение. Неврология, нейропсихиатрия, психосоматика. 2011; 3 (1): 27–33. / Parfenov V.A., Starchina Iu.A. Kognitivnye narusheniia u patsientov s arterial'noi gipertenziei i ikh lechenie. Nevrologiia, neiropsikhiatriia, psikhosomatika. 2011; 3 (1): 27–33. [in Russian]
36. Launer LJ, Masaki K, Petrovitch H et al. The association between midlife blood pressure levels and late-life cognitive function: the Honolulu-Asia Aging Study. JAMA 1995; 274: 1846–51. PMID: 7500533.
37. Парфенов В.А., Остроумова Т.М., Остроумова О.Д., Павлеева Е.Е. Особенности клинической картины у пациентов среднего возраста с эссенциальной артериальной гипертензией. Терапевтический архив. 2018; 90 (9): 15–26. https:/doi.org/ 10.26442/terarkh201890915-26 / Parfenov V.A., Ostroumova T.M., Ostroumova O.D., Pavleeva E.E. Osobennosti klinicheskoi kartiny u patsientov srednego vozrasta s essentsial'noi arterial'noi gipertenziei. Therapeutic Archive. 2018; 90 (9): 15–26. https:/doi.org/ 10.26442/terarkh201890915-26  [in Russian]
38. Almeida OP, Garrido GJ, Beer C et al. Cognitive and brain changes associated with ischaemic heart disease and heart failure. European Heart Journal 2012; 33 (14): 1769–76. DOI: https://doi.org/10.1093/eurheartj/ehr467
39. Тарасова И.В., Вольф Н.В., Сырова И.Д. и др. Умеренные когнитивные расстройства у пациентов с ишемической болезнью сердца: клинико-демографические и ЭЭГ-корреляты. Журн. неврологии и психиатрии им. С.С. Корсакова. 2014; 114 (12): 89–93. DOI: 10.17116/jnevro201411412189-93 / Tarasova I.V., Vol'f N.V., Syrova I.D. i dr. Umerennye kognitivnye rasstroistva u patsientov s ishemicheskoi bolezn'iu serdtsa: kliniko-demograficheskie i EEG-korreliaty. Zhurn. nevrologii i psikhiatrii im. S.S. Korsakova. 2014; 114 (12): 89–93. DOI: 10.17116/jnevro201411412189-93 [in Russian]
40. Kalantarian S, Ruskin JN. Atrial fibrillation and cognitive decline: phenomenon or epiphenomenon? Cardiol Clin 2016; 34: 279–85.
41. Graves KG, May HT, Jacobs V et al. Atrial fibrillation incrementally increases dementia risk across all CHADS2 and CHA2DS2VASc strata in patients receiving long-term warfarin. Am Heart J 2017; 188: 93–8.
42. Santangeli P, Di Biase L, Bai R et al. Atrial fibrillation and the risk of incident dementia: a meta-analysis. Heart Rhythm 2012; 9: 1761–8.
43. Bennett SJ, Sauve MJ. Cognitive deficits in patients with heart failure: a review of the literature. J Cardiovasc Nurs 2003; 18 (3): 219–42.
44. Vogels RL, Scheltens P, Schroeder-Tanka JM, Weinstein HC. Cognitive impairment in heart failure: a systematic review of the literature. Eur J Heart Fail 2007; 9 (5): 440–9.
45. Боголепова А.Н., Семушкина Е.Г., Смирнова М.Ю., Грачева И.Ю. Когнитивные функции у больных с кардиальной патологией. Лечащий врач. 2010; 5: 7–10. / Bogolepova A.N., Semushkina E.G., Smirnova M.Iu., Gracheva I.Iu. Kognitivnye funktsii u bol'nykh s kardial'noi patologiei. Lechashchii vrach. 2010; 5: 7–10. [in Russian]
46. Harkness K, Demers С. Screening for cognitive deficits using the Montreal cognitive assessment tool in outpatients ≥65 years of age with heart failure. Am J Cardiol 2011; 107: 1203–7.
47. Камчатнов П.Р., Михайлова Н.А., Морозова Ю.А. Применение рац-гопантеновой кислоты в лечении пациентов с сочетанной соматической и неврологической патологией с умеренно выраженными аффективными расстройствами. Consilium Medicum. Неврология и ревматология (Прил.) 2016; 1: 13–9. / Kamchatnov P.R., Mikhaylova N.A., Morozova Yu.A. The use of rac-hopantenic acid in the treatment of patients with concomitant somatic and neurological disorders with moderate to severe mood disorders. Consilium Medicum. Neurology and Rheumatology (Suppl.). 2016; 1: 13–9. [in Russian]
48. Камчатнов П.Р. Хронические расстройства мозгового кровообращения – возможности метаболической терапии. Рус. мед. журн. 2008; 5: 274–6. / Kamchatnov P.R. Khronicheskie rasstroistva mozgovogo krovoobrashcheniia – vozmozhnosti metabolicheskoi terapii. Rus. med. zhurn. 2008; 5: 274–6. [in Russian]
49. Канаева Л.С., Вазагаева Т.И., Ястребова В.В. Перспективы применения препарата Пантогам актив у больных с астеническими расстройствами. Психиатрия и психофармакотерапия. 2009; 11 (6): 34–9. / Kanaeva L.S., Vazagaeva T.I., Iastrebova V.V. Perspektivy primeneniia preparata Pantogam aktiv u bol'nykh s astenicheskimi rasstroistvami. Psychiatry and Psychopharmacotherapy. 2009; 11 (6): 34–9. [in Russian]
50. Пантогам и Пантогам актив. Клиническое применение и фундаментальные исследования. Сб. науч. ст. Под ред. В.М.Копелевича. М.: Триада-фарм, 2009. / Pantogam i Pantogam aktiv. Klinicheskoe primenenie i fundamental'nye issledovaniia. Sb. nauch. st. Pod red. V.M.Kopelevicha. M.: Triada-farm, 2009. [in Russian]
51. Путилина М.В. Тревожные расстройства у пациентов с гипертонической энцефалопатией. Мед. совет. 2011; 3–4: 107–10. / Putilina M.V. Trevozhnye rasstroistva u patsientov s gipertonicheskoi entsefalopatiei. Med. sovet. 2011; 3–4: 107–10. [in Russian]
52. Смулевич А.Б., Волель Б.А., Терновая Е.С., Никитина Ю.М. Применение препарата пантогам актив (D-, L-гопантеновая кислота) в терапии когнитивных и тревожных расстройств у пациентов с артериальной гипертензией. Журн. неврологии и психиатрии им. С.С.Корсакова. 2015; 115 (12): 40–9. DOI: https: //doi.org/10.17116/jnevro201511511240-49 / Smulevich A.B., Volel' B.A., Ternovaia E.S., Nikitina Iu.M. Primenenie preparata pantogam aktiv (D-, L-gopantenovaia kislota) v terapii kognitivnykh i trevozhnykh rasstroistv u patsientov s arterial'noi gipertenziei. Zhurn. nevrologii i psikhiatrii im. S.S.Korsakova. 2015; 115 (12): 40–9. DOI: https: //doi.org/10.17116/jnevro201511511240-49 [in Russian]
53. Конради А.О., Полуничева Е.В. Недостаточная приверженность к лечению артериальной гипертензии: причины и пути коррекции. Артериальная гипертензия. 2004; 10 (3): 12–5. / Konradi A.O., Polunicheva E.V. Nedostatochnaia priverzhennost' k lecheniiu arterial'noi gipertenzii: prichiny i puti korrektsii. Arterial'naia gipertenziia. 2004; 10 (3): 12–5. [in Russian]
54. Медведев М.Э., Албантова К.А. Пантогам актив при лечении невротических, связанных со стрессом, и соматоформных расстройств у больных кардиологического стационара. Consilium Medicum. 2009; 11 (2): 15–9. / Medvedev M.E., Albantova K.A. Pantogam aktiv pri lechenii nevroticheskikh, sviazannykh so stressom, i somatoformnykh rasstroistv u bol'nykh kardiologicheskogo statsionara. Consilium Medicum. 2009; 11 (2): 15–9. [in Russian]
55. Баранов А.П., Струтынский А.В., Ойноткинова О.Ш. и др. Возможности терапии тревожно-депрессивных расстройств у больных с хронической сердечной недостаточностью. Рос. кардиол. журн. 2017; 1: 128–35. DOI: https: //doi.org/10.15829/1560-4071-2017-1-128-135 / Baranov A.P., Strutynskii A.V., Oinotkinova O.Sh. i dr. Vozmozhnosti terapii trevozhno-depressivnykh rasstroistv u bol'nykh s khronicheskoi serdechnoi nedostatochnost'iu. Ros. kardiol. zhurn. 2017; 1: 128–35. DOI: https: //doi.org/10.15829/1560-4071-2017-1-128-135 [in Russian]
56. Медведев В.Э. Профилактика и терапия психопатологических расстройств у пациентов с сердечно-сосудистыми заболеваниями. Неврология, нейропсихиатрия, психосоматика. 2012; 3: 54–9. / Medvedev V.E. Profilaktika i terapiia psikhopatologicheskikh rasstroistv u patsientov s serdechno-sosudistymi zabolevaniiami. Nevrologiia, neiropsikhiatriia, psikhosomatika. 2012; 3: 54–9. [in Russian]

________________________________________________

1. Depression and Other Common Mental Disorders. Global Health Estimates. World Health Organization. Switzerland, 2017. http://apps.who.int/iris/bitstream /10665/254610/1/WHO-MSD-MER-2017.2-eng
2. Fedotova A.V. Trevozhno-depressivnye rasstroistva v obshcheklinicheskoi praktike. Ratsional'naia farmakoterapiia v kardiologii. 2008; 3: 83–8. [in Russian]
3. Suls J, Bunde J. Anger, Anxiety, and Depression as Risk Factors for Cardiovascular Disease: The Problems and Implications of Overlapping Affective Dispositions. Psychological Bulletin 2005; 131 (2): 260–300. DOI: 10.1037/0033-2909.131.2.260
4. Krasnov V.N. Obrazovatel'naia programma po depressivnym rasstroistvam. V 3 t. T. 2. M.: Moskovskii NII psikhiatrii, 2010. [in Russian]
5. Oganov R.G. Materialy simpoziuma: "Depressiia v kardiologii: bol'she, chem faktor riska". Rossiiskii natsional'nyi kongress kardiologov. M., 2003; s. 1–4. [in Russian]
6. Chazov E.I. Depressiia kak faktor razvitiia i progressirovaniia serdechno-sosudistykh zabolevanii. Serdechnaia nedostatochnost'. 2003; 1: 6–8. [in Russian]
7. Carney RM, Freeland KE, Sheline YI et al. Depression and coronary heart disease: a review for cardiologists. Clin Cardiol 1997; 20: 196–200.
8. Januzzi JL Jr, Stern TA, Pasternak RC et al. The influence of anxiety and depression on outcomes of patients with coronary artery disease. Arch Intern Med 2000; 160: 1913–21.
9. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease. Arch Gen Psychiatry 1998; 55: 580–92.
10. Freedland K, Rich M, Skala J et al. Prevalence of depression in hospitalized patients with congestive heart failure. Psychosom Med 2003; 65: 119–28.
11. Easton K, Coventry P, Lovell K et al. Prevalence and Measurement of Anxiety in Samples of Patients With Heart Failure. J Cardiovascular Nursing 2016; 31 (4): 367–79. DOI: 10.1097/jcn.0000000000000265
12. Chazov E.I., Oganov R.G., Pogosova G.V. i dr. Kliniko-epidemiologicheskaia programma izucheniia depressii v kardiologicheskoi praktike: u bol'nykh arterial'noi gipertoniei i ishemicheskoi bolezn'iu serdtsa (KOORDINATA): rezul'taty mnogotsentrovogo issledovaniia. Kardiologiia. 2007; 47 (3): 28–37. [in Russian]
13. Pogosova G.V., Romasenko L.V. Kliniko-epidemiologicheskie kharakteristiki patsientov pozhilogo vozrasta, stradaiushchikh serdechno-sosudistymi zabolevaniiami, komorbidnymi s depressivnymi rasstroistvami (po rezul'tatam mnogotsentrovogo prospektivnogo issledovaniia KOORDINATA). Therapeutic Archive. 2007; 10: 79–82. [in Russian]
14. Davidson KW. Depression and Coronary Heart Disease. ISRN Cardiology 2012; 1–18. DOI: 10.5402/2012/743813
15. Wulsin LR. Is Depression a Major Risk Factor for Coronary Disease? A Systematic Review of the Epidemiologic Evidence. Harvard Rev Psychiatry 2004; 12 (2): 79–93. DOI: 10.1080/10673220490447191
16. Black D, Zimmerman M, Coryell W. Cigarette smoking and psychiatric disorder in a community sample. Ann Clin Psychiatry 1999; 11: 129–36.
17. Kritz-Silverstein D, Barrett-Connor E, Corbeau C. Crosssectional and prospective study of exercise and depressed mood in the elderly: The Rancho Benardo study. Am J Epidemiol 2000; 153: 596–603.
18. Weidner G, Sexton G, McLellarn R et al. The role of Type A behavior and hostility in an elevation of plasma lipids in adult women and men. Psychosomatic Med 1987; 51: 112–22.
19. Anderson RJ, Freedland K, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: A metaanalysis. Diabetes Care 2001; 24: 1069–78.
20. Lauzon C, Beck CA, Huynh T et al. Depression and prognosis following hospitaladmission because of acute myocardial infarction. Can Med Assoc J 2003; 168: 547–52.
21. Van Melle J P, de Jonge P, Spijkerman TA et al. Prognostic Association of Depression Following Myocardial Infarction With Mortality and Cardiovascular Events: A Meta-analysis. Psychosomatic Med 2004; 66 (6): 814–22. DOI: 10.1097/01.psy.0000146294.82810.9
22. Barth J, Schumacher M, Herrmann‐Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: A meta‐ analysis. Psychosom Med 2004; 66: 802–13.
23. Ladwig KH, Roll G, Breithardt G et al. Post‐infarction depression and incomplete recovery 6 months after acute myocardial infarction. Lancet 1994; 343: 20–3.
24. Soderman E, Lisspers J, Sundin O. Depression as a predictor of return to work in patients with coronary artery disease. Soc Sci Med 2003; 56: 193–202.
25. DiMatteo M, Lepper H, Croghan T. Depression is a risk factor for noncompliance with medical treatment. Arch Intern Med 2000; 160: 2101–7.
26. Lane D, Carroll D, Ring C et al. Predictors of attendance at cardiac rehabilitation after myocardial infarction. J Psychosom Res 2001; 51: 497–501.
27. Rutledge Т, Vaccarino V, Johnson BD et al. Depression and cardiovascular health care costs among women with suspected myocardial ischemia. Prospective results from the WISE (Women’s Ischemia Syndrome Evaluation) Study, 13. J Am College Cardiol 2009; 53 (2): 176–83.
28. Frasure-Smith N, Lesperance F, Gravel G et al. Depression and health-care costs daring the first year following myocardial infarction. J Psychosomatic Res 2000; 48 (4–5): 471–8.
29. Lange HW, Herrmann-Lingen C. Depressive symptoms predict recurrence of atrial fibrillation after cardioversion. J Psychosom Res 2007; 63: 509–13.
30. Frasure-Smith N, Lespérance F, Habra M et al. Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure. Circulation 2009; 120 (2): 134–40. DOI: 10.1161/CIRCULATIONAHA.109.851675
31. Von Eisenhart Rothe AF, Goette A, Kirchhof P et al. Depression in paroxysmal and persistent atrial fibrillation patients: a cross-sectional comparison of patients enroled in two large clinical trials. Europace 2014; 16: 812–9.
32. Duma S.N. Otsenka klinicheskoi effektivnosti neiprotektorov, vliiaiushchikh na sistemu gamma-aminomaslianoi kisloty, pri lechenii kognitivnykh rasstroistv u patsientov s distsirkuliatornoi entsefalopatiei I–II stadii. Farmateka. 2010; 15: 96–100. [in Russian]
33. Skoog I, Gustafson D. Clinical trials for primary prevention in dementia. In: Dementia therapeutic research. Rockwood K, Gauthier S, editors. London and New York: Taylor a Francis 2006; p. 189–212.
34. Obisesan TO, Obisesan OA, Martins S et al. High blood pressure, hypertension, and high pulse pressure are associated with poorer cognitive function in persons aged 60 and older: the Third National Health and Nutrition Examination Survey. J Am Geriatr Soc 2008; 56: 501–9. DOI: 10.1111/j.1532-5415.2007.01592.x
35. Parfenov V.A., Starchina Iu.A. Kognitivnye narusheniia u patsientov s arterial'noi gipertenziei i ikh lechenie. Nevrologiia, neiropsikhiatriia, psikhosomatika. 2011; 3 (1): 27–33. [in Russian]
36. Launer LJ, Masaki K, Petrovitch H et al. The association between midlife blood pressure levels and late-life cognitive function: the Honolulu-Asia Aging Study. JAMA 1995; 274: 1846–51. PMID: 7500533.
37. Parfenov V.A., Ostroumova T.M., Ostroumova O.D., Pavleeva E.E. Osobennosti klinicheskoi kartiny u patsientov srednego vozrasta s essentsial'noi arterial'noi gipertenziei. Therapeutic Archive. 2018; 90 (9): 15–26. https:/doi.org/ 10.26442/terarkh201890915-26  [in Russian]
38. Almeida OP, Garrido GJ, Beer C et al. Cognitive and brain changes associated with ischaemic heart disease and heart failure. European Heart Journal 2012; 33 (14): 1769–76. DOI: https://doi.org/10.1093/eurheartj/ehr467
39. Tarasova I.V., Vol'f N.V., Syrova I.D. i dr. Umerennye kognitivnye rasstroistva u patsientov s ishemicheskoi bolezn'iu serdtsa: kliniko-demograficheskie i EEG-korreliaty. Zhurn. nevrologii i psikhiatrii im. S.S. Korsakova. 2014; 114 (12): 89–93. DOI: 10.17116/jnevro201411412189-93 [in Russian]
40. Kalantarian S, Ruskin JN. Atrial fibrillation and cognitive decline: phenomenon or epiphenomenon? Cardiol Clin 2016; 34: 279–85.
41. Graves KG, May HT, Jacobs V et al. Atrial fibrillation incrementally increases dementia risk across all CHADS2 and CHA2DS2VASc strata in patients receiving long-term warfarin. Am Heart J 2017; 188: 93–8.
42. Santangeli P, Di Biase L, Bai R et al. Atrial fibrillation and the risk of incident dementia: a meta-analysis. Heart Rhythm 2012; 9: 1761–8.
43. Bennett SJ, Sauve MJ. Cognitive deficits in patients with heart failure: a review of the literature. J Cardiovasc Nurs 2003; 18 (3): 219–42.
44. Vogels RL, Scheltens P, Schroeder-Tanka JM, Weinstein HC. Cognitive impairment in heart failure: a systematic review of the literature. Eur J Heart Fail 2007; 9 (5): 440–9.
45. Bogolepova A.N., Semushkina E.G., Smirnova M.Iu., Gracheva I.Iu. Kognitivnye funktsii u bol'nykh s kardial'noi patologiei. Lechashchii vrach. 2010; 5: 7–10. [in Russian]
46. Harkness K, Demers С. Screening for cognitive deficits using the Montreal cognitive assessment tool in outpatients ≥65 years of age with heart failure. Am J Cardiol 2011; 107: 1203–7.
47. Kamchatnov P.R., Mikhaylova N.A., Morozova Yu.A. The use of rac-hopantenic acid in the treatment of patients with concomitant somatic and neurological disorders with moderate to severe mood disorders. Consilium Medicum. Neurology and Rheumatology (Suppl.). 2016; 1: 13–9. [in Russian]
48. Kamchatnov P.R. Khronicheskie rasstroistva mozgovogo krovoobrashcheniia – vozmozhnosti metabolicheskoi terapii. Rus. med. zhurn. 2008; 5: 274–6. [in Russian]
49. Kanaeva L.S., Vazagaeva T.I., Iastrebova V.V. Perspektivy primeneniia preparata Pantogam aktiv u bol'nykh s astenicheskimi rasstroistvami. Psychiatry and Psychopharmacotherapy. 2009; 11 (6): 34–9. [in Russian]
50. Pantogam i Pantogam aktiv. Klinicheskoe primenenie i fundamental'nye issledovaniia. Sb. nauch. st. Pod red. V.M.Kopelevicha. M.: Triada-farm, 2009. [in Russian]
51. Putilina M.V. Trevozhnye rasstroistva u patsientov s gipertonicheskoi entsefalopatiei. Med. sovet. 2011; 3–4: 107–10. [in Russian]
52. Smulevich A.B., Volel' B.A., Ternovaia E.S., Nikitina Iu.M. Primenenie preparata pantogam aktiv (D-, L-gopantenovaia kislota) v terapii kognitivnykh i trevozhnykh rasstroistv u patsientov s arterial'noi gipertenziei. Zhurn. nevrologii i psikhiatrii im. S.S.Korsakova. 2015; 115 (12): 40–9. DOI: https: //doi.org/10.17116/jnevro201511511240-49 [in Russian]
53. Konradi A.O., Polunicheva E.V. Nedostatochnaia priverzhennost' k lecheniiu arterial'noi gipertenzii: prichiny i puti korrektsii. Arterial'naia gipertenziia. 2004; 10 (3): 12–5. [in Russian]
54. Medvedev M.E., Albantova K.A. Pantogam aktiv pri lechenii nevroticheskikh, sviazannykh so stressom, i somatoformnykh rasstroistv u bol'nykh kardiologicheskogo statsionara. Consilium Medicum. 2009; 11 (2): 15–9. [in Russian]
55. Baranov A.P., Strutynskii A.V., Oinotkinova O.Sh. i dr. Vozmozhnosti terapii trevozhno-depressivnykh rasstroistv u bol'nykh s khronicheskoi serdechnoi nedostatochnost'iu. Ros. kardiol. zhurn. 2017; 1: 128–35. DOI: https: //doi.org/10.15829/1560-4071-2017-1-128-135 [in Russian]
56. Medvedev V.E. Profilaktika i terapiia psikhopatologicheskikh rasstroistv u patsientov s serdechno-sosudistymi zabolevaniiami. Nevrologiia, neiropsikhiatriia, psikhosomatika. 2012; 3: 54–9. [in Russian]

________________________________________________